Mapfre has delivered a powerful long term share price run, which naturally pushes investors to ask whether the current valuation is still grounded in the returns the insurer earns on its capital. With that kind of backdrop, the key issue now is whether the business is generating enough value from each euro invested to support where the stock trades today.
-
Over the past 5 years the share price has gained 213.5%, which places a lot of weight on the idea that Mapfre's capital is being put to work at attractive rates.
-
The insurer's model relies heavily on how efficiently it converts premiums and invested float into profit, so any shift in underwriting discipline or investment returns can meaningfully change what its capital base is really worth.
-
If you'd rather focus on earnings, this one's for you. See why Mapfre's 11.3x P/E tells a different valuation story .
The issue now is whether the returns Mapfre earns on its capital are strong and durable enough to justify the price investors are paying today.
If you want to explore the same question you are asking about Mapfre, you can review a broader range of insurers and capital-efficient businesses using 191 high quality undervalued stocks
Does Mapfre Look Undervalued on Excess Returns?
The Excess Returns model looks at how efficiently Mapfre turns its equity base into profits above the return investors require. That focus matters here because this insurer is priced at €4.37, so any misread on its profitability against book value can quickly change the investment case.
On the model's inputs, Mapfre carries Book Value of €3.27 per share and a Stable Book Value estimate of €3.43 per share, with analysts expecting Stable EPS of €0.45 per share. The framework assumes a Cost of Equity of €0.25 per share, leaving an Excess Return of €0.20 per share, which reflects the spread between what the business earns and what shareholders demand.
Average Return on Equity of 13.11% underpins those assumptions, with both the earnings and book value figures anchored to forward analyst estimates rather than backward looking history. Using these excess returns, the model implies an estimated intrinsic value that is substantially above the current €4.37 share price. This is where the detailed valuation output becomes useful for readers who want to test their own view. Find out what Mapfre could be worth using our Excess Returns estimate .
The Mapfre Narrative: What Would Justify Today's Price?
Narratives for Mapfre on Simply Wall St's Community page pick up where the valuation puzzle leaves off and explain what kind of future growth, profitability and earnings path would need to occur for the shares to be worth much more or meaningfully less than today's price.
Rather than relying on a single multiple or one model output, each scenario outlines the key assumptions behind its fair value so you can track those against actual results as they are reported.
Community views on Mapfre are split between one group that sees enough execution upside to keep backing the story and another that worries balance sheet pressure caps the appeal.
Bull case: roughly fairly valued
"The equity stake in Tuio and the plan to back its expansion across Europe and Latin America using Mapfre's existing footprint create an option on a separate digital distribution channel..."
Discover why this Narrative puts Mapfre at roughly fairly valued .
Bear case: 20% overvalued
"Although Mapfre expects the Safety Insurance deal to be accretive and cash generating, the planned mix of €700m Tier 2, €500m senior debt and additional bank funding is set to lower the solvency ratio by around 10 points..."
Explore why this Narrative puts Mapfre at 20% overvalued .
One more Mapfre check before you stop at the share price
The people steering Mapfre and the way their pay packets line up with your interests can reinforce the investment case or pull against it. That alignment question still needs an answer. See who runs Mapfre and how they are paid .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MAP.MC .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
